Variant report
Variant | nsv467215 |
---|---|
Chromosome Location | chr10:55943184-56019194 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | 10:55527193-55535408..10:55949104-55956834 | K562 | blood: | |
2 | chr10:55968347..55970600-chr10:55971292..55973381,2 | K562 | blood: | |
3 | chr10:55968347..55970600-chr10:55971292..55973381,2 | K562 | blood: | |
4 | chr10:55961337..55963211-chr10:57586910..57589588,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs375576450 | chr10:55962802-55962803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs372622051 | chr10:55962804-55962805 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs115707041 | chr10:55962869-55962870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs79627650 | chr10:55962883-55962884 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs182685628 | chr10:55962897-55962898 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555442504 | chr10:55962904-55962905 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs555291362 | chr10:55962913-55962914 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs568369115 | chr10:55962936-55962937 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs140648198 | chr10:55962944-55962945 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs79080348 | chr10:55963044-55963045 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs567118195 | chr10:55963052-55963053 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs187405172 | chr10:55963143-55963144 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs552948017 | chr10:55963144-55963145 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs7093533 | chr10:55963150-55963151 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs142871807 | chr10:55963152-55963153 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs190775055 | chr10:55963178-55963179 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs553238586 | chr10:55963259-55963260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs537118670 | chr10:55963265-55963266 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs577982770 | chr10:55963268-55963269 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs16905760 | chr10:55963315-55963316 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs116173073 | chr10:55963327-55963328 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs7092751 | chr10:55963331-55963332 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs183302011 | chr10:55963335-55963336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189246352 | chr10:55963358-55963359 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573617477 | chr10:55963360-55963361 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs147424611 | chr10:55963365-55963366 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs192290121 | chr10:55963390-55963391 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs139471654 | chr10:55963422-55963423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs575605581 | chr10:55963431-55963432 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs542710095 | chr10:55963444-55963445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs557206173 | chr10:55963449-55963450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs550365583 | chr10:55963451-55963452 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs112904018 | chr10:55963463-55963464 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs10740577 | chr10:55963500-55963501 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
35 | rs529656722 | chr10:55963527-55963528 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs377502788 | chr10:55963531-55963532 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs144986547 | chr10:55963562-55963563 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs144949376 | chr10:55963563-55963564 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs116898034 | chr10:55963577-55963578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs552076313 | chr10:55963589-55963590 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs184289940 | chr10:55963600-55963601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs201755803 | chr10:55966600-55966601 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs576097890 | chr10:55966606-55966607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs190625052 | chr10:55966677-55966678 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs140518345 | chr10:55966697-55966698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs11004137 | chr10:55966701-55966702 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs10740578 | chr10:55966721-55966722 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs550733059 | chr10:55966739-55966740 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs116787475 | chr10:55966745-55966746 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs150389793 | chr10:55966825-55966826 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Pancreatic endocrine tumor | 17639061 | CNVD |
Gastric cancer | 17908304 | CNVD |
Chordoma | 21602918 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Melanoma | 18172304 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Acute lymphoblastic leukemia | 20724749 | CNVD |
Autism | 22495311 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Prostate cancer | 18632612 | CNVD |
Autism | 18414403 | CNVD |
Cockayne syndrome | 18421352 | CNVD |
Glioblastoma | 16823260 | CNVD |
Medulloblastoma | 16968546 | CNVD |
Neuroblastoma | 17533364 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Glioma | 21971842 | CNVD |
Cancer | 21637783 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Obesity | 21956041 | CNVD |
Developmental delay | 21948486 | CNVD |
Intellectual disability | 21948486 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 21364760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Autism | 20841430 | CNVD |
Mental retardation | 17124404 | CNVD |
Epilepsy | 20923578 | CNVD |
Prostate cancer | 16573809 | CNVD |
Schizophrenia | 19329560 | CNVD |
Heart failure | 18772530 | CNVD |
Heart failure | 18854381 | CNVD |
Hyperglycemia | 19060297 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Glioblastoma multiforme | 22286061 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Usher syndrome | 20538994 | CNVD |
Glioblastoma multiforme | 17002787 | CNVD |
Colorectal cancer | 16774939 | CNVD |
Autism | 20858243 | CNVD |
Breast cancer | 22522925 | CNVD |
Usher type I cohort | 17277737 | CNVD |
Usher type I cohort | 21436283 | CNVD |
Leukemia | 21357790 | CNVD |
Medulloblastoma | 22832581 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Cancer | 20164919 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr10:55962800-55963600 | Enhancers | HUVEC | blood vessel |
2 | chr10:55966600-55967000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
3 | chr10:55987000-55987400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
4 | chr10:55987400-55990800 | Weak transcription | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
5 | chr10:55988600-55990800 | Weak transcription | ES-UCSF4 Cell Line | embryonic stem cell |
6 | chr10:55990800-55991400 | ZNF genes & repeats | H1 BMP4 Derived Trophoblast Cultured Cells | ES cell derived |
7 | chr10:55990800-55991600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
8 | chr10:56000800-56001800 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
9 | chr10:56000800-56002600 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
10 | chr10:56019000-56019200 | Active TSS | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |